title: Infliximab treatment of severe genital ulcers associated with Behçet disease.
authors.affiliation: Department of Dermatology, Aichi Medical University, Aichi, Japan.
authors.forename: Chikatoshi
authors.initials: C
authors.lastname: Kasugai
authors.affiliation: Department of Dermatology, Aichi Medical University, Aichi, Japan. Electronic address: dwatanab@aichi-med-u.ac.jp.
authors.forename: Daisuke
authors.initials: D
authors.lastname: Watanabe
authors.affiliation: Department of Dermatology, Aichi Medical University, Aichi, Japan.
authors.forename: Kimihiko
authors.initials: K
authors.lastname: Mizutani
authors.affiliation: Department of Dermatology, Aichi Medical University, Aichi, Japan.
authors.forename: Yuko
authors.initials: Y
authors.lastname: Masuda
authors.affiliation: Department of Ophthalmology, Aichi Medical University, Aichi, Japan.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Zako
authors.affiliation: Department of Rheumatology, Aichi Medical University, Aichi, Japan.
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Mukai
authors.affiliation: Department of Dermatology, Aichi Medical University, Aichi, Japan.
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Tamada
authors.affiliation: Department of Dermatology, Aichi Medical University, Aichi, Japan.
authors.forename: Yoshinari
authors.initials: Y
authors.lastname: Matsumoto
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications*; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D019233:Retreatment; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014456:Ulcer / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D016572:Cyclosporine; D000069285:Infliximab